CONNECT WITH US
HealthTech

HealthTech

Why old dogs might be able to teach Alzheimer's researchers new tricks

Medical Xpress logo

Published on

Add as a preferred source on Google
Why old dogs might be able to teach Alzheimer's researchers new tricks

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

Most people know someone with Alzheimer's disease. When I was growing up, my grandmother struggled with dementia, and I saw firsthand how difficult that was for our family.

That experience was one reason I became a neurotoxicologist who studies how misshapen proteins and inflammation in the brain can increase over time and cause dementia. While there are ways to treat the symptoms of dementia, researchers are still in search of a cure.

Alzheimer's disease and other types of dementia are difficult to study, in part because diagnosing these diseases early in people is challenging. These diseases typically begin developing two decades before most symptoms that would prompt someone to see a clinician. As a result, most researchers use mouse models to test potential therapies for Alzheimer's.

However, the effects of drugs developed in mice rarely translate to people. In fact, 99% of drugs developed for Alzheimer's that showed promise in the lab failed in human clinical trials. Brain aging is hard to study in mice, as they do not naturally have the buildup of misshapen proteins seen in dementia. Researchers can genetically modify mice to mimic what happens in a human brain, but it is difficult to mimic every aspect of dementia in one mouse.

So, scientists have set out to research other animals that naturally experience what happens in the brains of people with Alzheimer's or dementia.


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.